UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3496-3502

2008

Link zum Volltext

Verfügbarkeit prüfen

Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival

Journal of clinical oncology, 2011-04, Vol.29 (12), p.1539-1546

2011

Link zum Volltext

Verfügbarkeit prüfen

Understanding of Prognosis Among Parents of Children With Cancer: Parental Optimism and the Parent-Physician Interaction

Journal of clinical oncology, 2007-04, Vol.25 (11), p.1357-1362

2007

Link zum Volltext

Verfügbarkeit prüfen

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

Journal of clinical oncology, 1997-03, Vol.15 (3), p.928-937

1997

Link zum Volltext

Verfügbarkeit prüfen

Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome

Journal of clinical oncology, 2002-05, Vol.20 (10), p.2537-2544

2002

Link zum Volltext

Verfügbarkeit prüfen

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

Journal of clinical oncology, 1998-12, Vol.16 (12), p.3843-3850

1998

Link zum Volltext

Verfügbarkeit prüfen

Surgical care and outcomes in older patients with cancer through implementation of a pre-surgical toolkit (OPTI-Surg): Interim results of a phase III cluster randomized trial (Alliance A231601CD)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1541-1541

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4143-4143

2023

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 study of TAK-164, an anti-guanylyl cyclase C (GCC) antibody-drug conjugate (ADC), in patients (pts) with advanced gastrointestinal (GI) cancers expressing GCC

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3050-3050

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of AG-120, an IDH1 mutant enzyme inhibitor: Results from the cholangiocarcinoma dose escalation and expansion cohorts

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4015-4015

2017

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic targeting of extracellular FGFR2 activating deletions in intrahepatic cholangiocarcinoma

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.567-567

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.693-693

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of atezolizumab (atezo) and bevacizumab (bev) in a phase Ib study of microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC)

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.673-673

2017

Link zum Volltext

Verfügbarkeit prüfen

CheckMate 577: A randomized, double-blind, phase 3 study of adjuvant nivolumab (nivo) or placebo in pts with resected esophageal (E) or gastroesophageal junction (GEJ) cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS4131-TPS4131

2017

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase II trial of pembrolizumab (pembro) in previously-treated metastatic esophageal cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16072-e16072

2018

Link zum Volltext

Verfügbarkeit prüfen

CheckMate 577: A randomized, double-blind, phase 3 study of nivolumab (Nivo) or placebo in patients (Pts) with resected lower esophageal (E) or gastroesophageal junction (GEJ) cancer

Journal of clinical oncology, 2017-02, Vol.35 (4_suppl), p.TPS212-TPS212

2017

Link zum Volltext

Verfügbarkeit prüfen

ClarIDHy: A phase 3 multicenter randomized double-blind study of AG-120 versus placebo in patients with non-resectable or metastatic cholangiocarcinoma with an IDH1 mutation

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.TPS545-TPS545

2018

Link zum Volltext

Verfügbarkeit prüfen

ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.TPS4142-TPS4142

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Preoperative Oral Uracil and Tegafur Plus Leucovorin and Radiation Therapy in Rectal Cancer

Journal of clinical oncology, 2000-10, Vol.18 (20), p.3529-3534

2000

Link zum Volltext

Verfügbarkeit prüfen

Radioprotection study of topical norepinephrine in postsurgical breast cancer patients

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS9152-TPS9152

2012

Link zum Volltext

Verfügbarkeit prüfen

Smoking status and treatment outcome in patients with pancreatic cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e15676-e15676

2016

Link zum Volltext

Verfügbarkeit prüfen

Multicenter double-blind randomized phase II: FOLFOX + ziv-aflibercept/placebo for patients (pts) with chemo-naive metastatic esophagogastric adenocarcinoma (MEGA)

Journal of clinical oncology, 2016-02, Vol.34 (4_suppl), p.4-4

2016

Link zum Volltext

Verfügbarkeit prüfen

Automatic inpatient palliative care consultation (PCC): Too little, too late to impact quality of life for advanced cancer patients?

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e20565-e20565

2013

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind study of “Scrambler” therapy versus sham for painful chemotherapy-induced peripheral neuropathy (CIPN)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.9635-9635

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of RECIST 1.1 modifications on clinical trial eligibility

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e16555-e16555

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival

Understanding of Prognosis Among Parents of Children With Cancer: Parental Optimism and the Parent-Physician Interaction

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome

Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma

Surgical care and outcomes in older patients with cancer through implementation of a pre-surgical toolkit (OPTI-Surg): Interim results of a phase III cluster randomized trial (Alliance A231601CD)

A phase II study of nivolumab and ipilimumab with radiation therapy in patients with metastatic, microsatellite stable pancreatic adenocarcinoma

A phase 1 study of TAK-164, an anti-guanylyl cyclase C (GCC) antibody-drug conjugate (ADC), in patients (pts) with advanced gastrointestinal (GI) cancers expressing GCC

Phase I study of AG-120, an IDH1 mutant enzyme inhibitor: Results from the cholangiocarcinoma dose escalation and expansion cohorts

Therapeutic targeting of extracellular FGFR2 activating deletions in intrahepatic cholangiocarcinoma

Phase Ib study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer

Efficacy and safety of atezolizumab (atezo) and bevacizumab (bev) in a phase Ib study of microsatellite instability (MSI)-high metastatic colorectal cancer (mCRC)

CheckMate 577: A randomized, double-blind, phase 3 study of adjuvant nivolumab (nivo) or placebo in pts with resected esophageal (E) or gastroesophageal junction (GEJ) cancer

Multicenter phase II trial of pembrolizumab (pembro) in previously-treated metastatic esophageal cancer

CheckMate 577: A randomized, double-blind, phase 3 study of nivolumab (Nivo) or placebo in patients (Pts) with resected lower esophageal (E) or gastroesophageal junction (GEJ) cancer

ClarIDHy: A phase 3 multicenter randomized double-blind study of AG-120 versus placebo in patients with non-resectable or metastatic cholangiocarcinoma with an IDH1 mutation

ClarIDHy: A phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation

Phase I Study of Preoperative Oral Uracil and Tegafur Plus Leucovorin and Radiation Therapy in Rectal Cancer

Radioprotection study of topical norepinephrine in postsurgical breast cancer patients

Smoking status and treatment outcome in patients with pancreatic cancer

Multicenter double-blind randomized phase II: FOLFOX + ziv-aflibercept/placebo for patients (pts) with chemo-naive metastatic esophagogastric adenocarcinoma (MEGA)

Automatic inpatient palliative care consultation (PCC): Too little, too late to impact quality of life for advanced cancer patients?

A randomized, double-blind study of “Scrambler” therapy versus sham for painful chemotherapy-induced peripheral neuropathy (CIPN)

Impact of RECIST 1.1 modifications on clinical trial eligibility

Aktive Filter

Suchergebnisse filtern